As for NGS, it would be recommendable to study differential mutational patterns in TCF3 and ID3, which are recurrently mutated in BL, and EZH2, CREBBP, and KMT2D, which are mutated in other lymphomas. This evidence concerns the gene KMT2D and Burkitt lymphoma.